benzothiazole has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnickel, G; Boeddrich, A; Böttcher, H; Bröcker, W; Dunkel, I; Engemann, S; Heiser, V; Herhaus, C; Lehrach, H; Lurz, R; Nordhoff, E; Rautenberg, S; Schugardt, N; Waelter, S; Wanker, EE | 1 |
Barker, AL; Bates, GP; Beunard, JL; Hockly, E; Holt, K; Lowden, PA; Moffitt, H; Moolman, DL; Revington, AP; Sathasivam, K; Sunshine, S; Tse, J; Wanker, EE; Woodman, B | 1 |
2 other study(ies) available for benzothiazole and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay.
Topics: Benzothiazoles; Blotting, Western; Cell Line; Electrophoresis, Polyacrylamide Gel; Exons; Fluorescent Antibody Technique, Indirect; Humans; Huntingtin Protein; Huntington Disease; Microscopy, Electron; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thiazoles | 2002 |
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.
Topics: Animals; Benzothiazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Genotype; Huntington Disease; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Neuroprotective Agents; Organ Culture Techniques; Riluzole; Thiazoles | 2006 |